Rhodes Jason P (CIK 1577014) reported 82 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-17). Recent activity: Sell DYN (268,354 shares), Sell DYN (94,415 shares), Sell DYN (63,643 shares), Sell DYN (1.4M shares), Sell DYN (478,377 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-17 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 268,354 | $7.0M |
| 2026-08-17 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 94,415 | $2.5M |
| 2026-08-17 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 63,643 | $1.7M |
| 2026-08-17 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 1.4M | $34.0M |
| 2026-08-17 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 478,377 | $12.0M |
| 2026-08-17 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 322,465 | $8.1M |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 14,844 | $350,615 |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 127,182 | $2.9M |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 100,019 | $2.3M |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 124,379 | $2.9M |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 29,587 | $698,845 |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 62,543 | $1.4M |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 253,039 | $5.8M |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 49,193 | $1.1M |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 11,665 | $275,527 |
| 2026-07-08 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 5,000 | $118,050 |
| 2026-06-30 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 162,954 | $3.5M |
| 2026-06-30 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 81,903 | $1.7M |
| 2026-06-30 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 64,411 | $1.4M |
| 2026-06-30 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 102,969 | $2.2M |
| 2026-06-30 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 51,756 | $1.1M |
| 2026-06-30 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 40,702 | $860,440 |
| 2026-06-26 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 77,855 | $1.6M |
| 2026-06-26 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 39,131 | $826,838 |
| 2026-06-26 | Dyne Therapeutics, Inc. (DYN) | Director | Sell | 30,774 | $650,255 |
Source: SEC Form 4 filings · as of 2026-08-17